Funding Agency

Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN035160-005
Application #
7329507
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2006
Total Cost
Indirect Cost

  Institution

Name
Regents of the University of
Department
Type
DUNS #
City
State
Country
Zip Code

  Publications

Morgan, Timothy R; Osann, Kathryn; Bottiglieri, Teodoro et al. (2015) A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum ?-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP. Cancer Prev Res (Phila) 8:864-72
Gillen, Daniel L; Meyskens, Frank L; Morgan, Timothy R et al. (2015) A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum. Cancer Prev Res (Phila) 8:222-30
Linden, Kenneth G; Leachman, Sancy A; Zager, Jonathan S et al. (2014) A randomized, double-blind, placebo-controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiology. Cancer Prev Res (Phila) 7:496-504
Carroll, Robert E; Benya, Richard V; Turgeon, Danielle Kim et al. (2011) Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila) 4:354-64